S. Belman, MSc, School of Medicine, University of Utah, Salt Lake City, Utah, USA, and Wellcome Sanger Institute, University of Cambridge, Hinxton, UK.
J.A. Walsh, MD, C. Carroll, MSc, M. Milliken, MD, MPH, K. Callis Duffin, MD, G.G. Krueger, MD, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
J Rheumatol. 2021 Oct;48(10):1559-1565. doi: 10.3899/jrheum.201123. Epub 2021 Apr 15.
Delays in the diagnosis and treatment of psoriatic arthritis (PsA) are common. These delays contribute to impairments in quality of life and joint damage. This study aims to calculate the incidence rate of PsA over time and identify clinical features that may be used for PsA prediction in patients with psoriasis (PsO).
The study population for PsA incidence analysis included 1128 participants enrolled in the Utah Psoriasis Initiative between 2002 and 2014. Clinical evaluation and medical record review were performed to identify new cases of PsA after enrollment. To identify PsO features associated with PsA, the population was restricted to 627 participants who did not have PsA before PsO phenotyping and had been followed up for subsequent PsA diagnosis. We conducted Cox proportional hazard regressions to estimate the HR of PsA associated with PsO characteristics and other health-related features.
PsA incidence rate increased for > 60 years following PsO onset (trend < 0.0001). There was a significant association between PsA and induration severity in untreated lesions ( < 0.001, HR 1.46), history of fingernail involvement ( < 0.001, HR 2.38), pustular PsO ( < 0.001, HR 3.32), fingernail involvement at enrollment ( < 0.001, HR 2.04), and Koebner phenomenon ( < 0.001, HR 1.90). Multivariate analysis yielded a model that included a history of fingernail involvement ( < 0.001, HR 2.16) and untreated induration ( < 0.001, HR 1.41).
Risk of PsA increases steadily for > 60 years following PsO onset. Patient-reported history of PsO characteristics has greater predictive power than physician-measured features at enrollment visits. The characteristics identified in this study provide guidance for screening for PsA risk in patients with PsO.
银屑病关节炎(PsA)的诊断和治疗延误很常见。这些延误导致生活质量受损和关节损伤。本研究旨在计算随时间推移 PsA 的发病率,并确定可能用于预测银屑病(PsO)患者发生 PsA 的临床特征。
PsA 发病率分析的研究人群包括 2002 年至 2014 年间参加犹他州银屑病倡议的 1128 名参与者。在入组后进行临床评估和病历审查以确定新的 PsA 病例。为了确定与 PsA 相关的 PsO 特征,将人群限制在 627 名在进行 PsO 表型分析之前没有 PsA 且随后进行了 PsA 诊断的参与者。我们进行了 Cox 比例风险回归以估计与 PsO 特征和其他健康相关特征相关的 PsA 的 HR。
PsO 发病后 >60 年 PsA 的发病率增加(趋势<0.0001)。在未经治疗的病变中,未治疗的硬结严重程度(<0.001,HR 1.46)、指甲受累史(<0.001,HR 2.38)、脓疱型 PsO(<0.001,HR 3.32)、入组时的指甲受累(<0.001,HR 2.04)和 Koebner 现象(<0.001,HR 1.90)与 PsA 显著相关。多变量分析得出了一个包含指甲受累史(<0.001,HR 2.16)和未经治疗的硬结(<0.001,HR 1.41)的模型。
PsO 发病后 >60 年,PsA 的发病风险稳步增加。患者报告的 PsO 特征史比入组时医生测量的特征具有更高的预测能力。本研究中确定的特征为筛查银屑病患者的 PsA 风险提供了指导。